{
    "clinical_study": {
        "@rank": "109263", 
        "arm_group": [
            {
                "arm_group_label": "Patients with anorexia nervosa", 
                "arm_group_type": "Experimental", 
                "description": "This arm is the experimental arm composed of patients"
            }, 
            {
                "arm_group_label": "controls subjects", 
                "arm_group_type": "Active Comparator", 
                "description": "This arm is composed of healthy volunteers"
            }
        ], 
        "brief_summary": {
            "textblock": "Nutritional deprivation of adolescent girls with anorexia nervosa (AN) reduces the bone mass\n      acquisition. A better understanding of this process would improve the medical treatment of\n      bone alteration and its long-term consequences.\n\n      160 patients (age < 38 yr) with AN and 160 age-matched controls (CON) will be enrolled in\n      this study. The areal bone mineral density (aBMD) will be determined using dual-X-ray\n      absorptiometry. Calciotropic hormones, bone turnover markers will be concomitantly\n      evaluated."
        }, 
        "brief_title": "Bone Loss in Patients With Anorexia Nervosa", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Patients With Anorexia Nervosa", 
        "condition_browse": {
            "mesh_term": [
                "Anorexia", 
                "Anorexia Nervosa"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Informed Consent\n\n          -  Health Insurance regimen or benefit from an health insurance regimen\n\n          -  Aged from 14 to 38 years old\n\n          -  Women\n\n          -  No pregnant\n\n        Specific inclusion criteria for patient:\n\n        Patient suffering from anorexia nervosa defined by criteria of Diagnostic and Statistical\n        Manual of Mental Disorders (DSM-IV)\n\n        Specific inclusion criteria for controls:\n\n          -  Normal menstrual cycles,\n\n          -  No lifetime history of eating disorders,\n\n          -  BMI between 18 and 25 kg/m\u00b2\n\n        Exclusion Criteria:\n\n          -  use of treatments may be modify bone mass (bisphosphonates,\u2026)\n\n          -  Disease or treatment may be induce osteoporosis\n\n          -  In exclusion period in relation with another study\n\n          -  Law protected subject"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "38 Years", 
            "minimum_age": "14 Years"
        }, 
        "enrollment": {
            "#text": "320", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01907464", 
            "org_study_id": "UF 8751"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Patients with anorexia nervosa", 
                    "controls subjects"
                ], 
                "description": "description of weight, height, Bone Mass Index, dietary questionnary, amenorrhea time, pathology time for the two arms", 
                "intervention_name": "clinical parameters description", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Patients with anorexia nervosa", 
                    "controls subjects"
                ], 
                "description": "description of DMO, mass, basal metabolism, IGF-1/IGFBP-3 for the two arms", 
                "intervention_name": "para clinical parameters description", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Patients with anorexia nervosa", 
                    "controls subjects"
                ], 
                "description": "dosing of leptine, leptine receptor, adiponectine, ghreline for the two arms", 
                "intervention_name": "hormonal parameters dosing", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Patients with anorexia nervosa", 
                    "controls subjects"
                ], 
                "description": "dosing of osteocalcine, bone alkalin phosphatase, C-telopeptide of type-I collagene, osteoprotegerine/ RANKL for the two arms", 
                "intervention_name": "bone modeling markers dosing", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Anorexia nervosa", 
            "Bone mineral density", 
            "Teenagers or young women", 
            "Bone remodelling markers"
        ], 
        "lastchanged_date": "July 22, 2013", 
        "location": {
            "contact": {
                "email": "l-maimoun@chu-montpellier.fr", 
                "last_name": "Laurent LM MAIMOUN, PhD", 
                "phone": "+33 4 67 33 79 99"
            }, 
            "facility": {
                "address": {
                    "city": "Montpellier", 
                    "country": "France", 
                    "zip": "34295"
                }, 
                "name": "CHU de Montpellier - D\u00e9partement d'Endocrinologie Diab\u00e8te"
            }, 
            "investigator": {
                "last_name": "Patrick PL LEFEBVRE, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Physiopathology of Bone Loss in Young Patient With Anorexia Nervosa", 
        "overall_contact": {
            "email": "p-lefebvre@chu-montpellier.fr", 
            "last_name": "Patrick PL LEFEBVRE, MD", 
            "phone": "+33 4 67 33 84 31"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Montpellier", 
            "last_name": "Patrick PL LEFEBVRE, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Committee for the Protection of Personnes", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome is to model the bone mass acquisition in young women with anorexia nervosa.", 
            "measure": "Dual-X-ray absorptiometry (DEXA)", 
            "safety_issue": "No", 
            "time_frame": "at Day 0 (time of the inclusion visit)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01907464"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "One of the secondary outcome is to identify biological factors associated with bone demineralisation.", 
                "measure": "Biological parameters identification", 
                "safety_issue": "No", 
                "time_frame": "At day 0 (time of the inclusion visit)"
            }, 
            {
                "description": "One of the secondary outcome is to identify the clinical factors associated with bone demineralisation.", 
                "measure": "clinical parameters identification", 
                "safety_issue": "No", 
                "time_frame": "At Day 0 (at time of the the inclusion visit)"
            }
        ], 
        "source": "University Hospital, Montpellier", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Montpellier", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}